MedTrace Logo

Mantle Irradiation for Hodgkin's Disease

NCT00165269 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2009-11-02

No results posted yet for this study

Summary

The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.

Conditions

  • Hodgkin's Disease

Interventions

PROCEDURE

Mantle irradiation

Limited to above the diaphragm

Sponsors & Collaborators

Principal Investigators

  • Peter Mauch, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1992-05-31
Primary Completion
2000-06-30
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165269 on ClinicalTrials.gov